{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:23:26Z","timestamp":1755217406689,"version":"3.43.0"},"reference-count":35,"publisher":"Harborside Press, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Neuroendocrine tumors (NETs) are a diverse group of malignancies with increasing incidence. Early diagnosis is challenging\u2014most patients present with advanced disease, which is associated with a heavy symptom burden. The role of palliative care in the management of NETs is critical but inadequately explored. We sought to investigate the utilization of palliative care and examine racial disparities in end-of-life (EoL) care among patients with NETs. <jats:bold>Methods:<\/jats:bold> We analyzed National Inpatient Sample (NIS) data from 2016 to 2020, including hospitalizations involving patients with NETs who experienced inpatient mortality. Palliative care consultation rates, do-not-resuscitate (DNR) status, and aggressive treatment interventions were assessed. Comparative analysis between White and Black patients was conducted using logistic regression to determine associations with palliative care consultation and EoL care. <jats:bold>Results:<\/jats:bold> Among 7,215 patients with NETs, 60.7% received palliative care consultation at EoL. Palliative care consultation was more frequent in males and patients aged 50\u201375 years. It was associated with a higher likelihood of DNR code status (OR, 5.2; 95% CI, 4.7\u20135.8) and a reduced incidence of aggressive treatments such as mechanical ventilation (OR, 0.47; 95% CI, 0.43\u20130.52) and vasopressor administration (OR, 0.70; 95% CI, 0.60\u20130.82). Black patients were less likely to receive palliative care consultation (adjusted OR, 0.70; 95% CI, 0.62\u20130.80) and to have DNR code status (adjusted OR, 0.81; 95% CI, 0.71\u20130.92), and were more likely to undergo aggressive interventions such as mechanical ventilation at EoL (adjusted OR, 1.54; 95% CI, 1.35\u20131.76). <jats:bold>Conclusions:<\/jats:bold> Our study shows that approximately 40% of hospitalized patients with NETs do not receive palliative care consultation at EoL, and that significant racial disparities exist. These findings underscore the need for enhanced integration of palliative care and targeted interventions to address racial disparities in EoL care among patients with NETs.<\/jats:p>","DOI":"10.6004\/jnccn.2025.7024","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T16:05:54Z","timestamp":1749744354000},"page":"314-318","source":"Crossref","is-referenced-by-count":0,"title":["End-of-Life Care Among Patients With Neuroendocrine Tumors: Underutilization of Palliative Care and Racial Disparities"],"prefix":"10.6004","volume":"23","author":[{"given":"Suriya","family":"Baskar","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udhayvir Singh","family":"Grewal","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA"},{"name":"Holden Comprehensive Cancer Center, Iowa City, IA"},{"name":"University of Iowa Neuroendocrine Tumor Program, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Cancer","first-page":"589","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet J","year":"2015","unstructured":"Hallet J, Law CHL, Cukier M,  Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 2015;121:589\u2013597."},{"key":"B2","series-title":"JAMA Oncol","first-page":"21","article-title":"Neuroendocrine tumors-less well known, often misunderstood, and rapidly growing in incidence","volume":"6","author":"Chauhan A","year":"2020","unstructured":"Chauhan A, Kohn E, Del Rivero J. Neuroendocrine tumors-less well known, often misunderstood, and rapidly growing in incidence. JAMA Oncol 2020;6:21\u201322."},{"key":"B3","series-title":"Endocr Relat Cancer","first-page":"R163","article-title":"Neuroendocrine tumor disease: an evolving landscape","volume":"19","author":"Frilling A","year":"2012","unstructured":"Frilling A, Akerstr\u00f6m G, Falconi M,  Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer 2012;19:R163\u2013185."},{"key":"B4","series-title":"J Clin Oncol","first-page":"3063","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao JC","year":"2008","unstructured":"Yao JC, Hassan M, Phan A,  One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063\u20133072."},{"key":"B5","series-title":"Lancet Oncol","first-page":"61","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin IM","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC,  Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61\u201372."},{"key":"B6","series-title":"Eur J Oncol Nurs","first-page":"541","article-title":"Patient experiences of having a neuroendocrine tumour: a qualitative study","volume":"17","author":"Feinberg Y","year":"2013","unstructured":"Feinberg Y, Law C, Singh S,  Patient experiences of having a neuroendocrine tumour: a qualitative study. Eur J Oncol Nurs 2013;17:541\u2013545."},{"key":"B7","series-title":"N Engl J Med","first-page":"733","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel JS","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A,  Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733\u2013742."},{"key":"B8","series-title":"Cochrane Database Syst Rev","first-page":"CD011129","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"Haun MW","year":"2017","unstructured":"Haun MW, Estel S, R\u00fccker G,  Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 2017;6:CD011129."},{"key":"B9","series-title":"J Palliat Med","first-page":"400","article-title":"A qualitative inquiry on palliative and end-of-life care policy reform","volume":"19","author":"Schreibeis-Baum HC","year":"2016","unstructured":"Schreibeis-Baum HC, Xenakis LE, Chen EK,  A qualitative inquiry on palliative and end-of-life care policy reform. J Palliat Med 2016;19:400\u2013407."},{"key":"B10","series-title":"J Pain Symptom Manage","first-page":"342","article-title":"Racial disparities in end-of-life care between black and white adults with metastatic cancer","volume":"61","author":"Perry LM","year":"2021","unstructured":"Perry LM, Walsh LE, Horswell R,  Racial disparities in end-of-life care between black and white adults with metastatic cancer. J Pain Symptom Manage 2021;61:342\u2013349.e1."},{"key":"B11","series-title":"J Natl Compr Canc Netw","first-page":"1131","article-title":"Racial disparities in end-of-life care among patients with prostate cancer: a population-based study","volume":"13","author":"Abdollah F","year":"2015","unstructured":"Abdollah F, Sammon JD, Majumder K,  Racial disparities in end-of-life care among patients with prostate cancer: a population-based study. J Natl Compr Canc Netw 2015;13:1131\u20131138."},{"key":"B12","series-title":"J Palliat Med","first-page":"548","article-title":"Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer","volume":"15","author":"Miesfeldt S","year":"2012","unstructured":"Miesfeldt S, Murray K, Lucas L,  Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer. J Palliat Med 2012;15:548\u2013554."},{"key":"B13","series-title":"Lancet","first-page":"1721","article-title":"Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial","volume":"383","author":"Zimmermann C","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M,  Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014;383:1721\u20131730."},{"key":"B14","series-title":"Arch Intern Med","first-page":"1821","article-title":"The relationship between age and the use of DNR orders in critical care patients: evidence for age discrimination","volume":"156","author":"Boyd K","year":"1996","unstructured":"Boyd K, Teres D, Rapoport J,  The relationship between age and the use of DNR orders in critical care patients: evidence for age discrimination. Arch Intern Med 1996;156:1821\u20131826."},{"key":"B15","series-title":"JCO Oncol Pract","first-page":"252","article-title":"Palliative care as a component of high-value and cost-saving care during hospitalization for metastatic cancer","volume":"24","author":"Lu S","year":"2025","unstructured":"Lu S, Rakovitch E, Hannon B,  Palliative care as a component of high-value and cost-saving care during hospitalization for metastatic cancer. JCO Oncol Pract 2025;24:252\u2013260."},{"key":"B16","series-title":"Ann Oncol","first-page":"vii72","article-title":"Gastrointestinal neuroendocrine tumors","volume":"21","author":"\u00d6berg KE","year":"2010","unstructured":"\u00d6berg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol 2010;21(Suppl 7):vii72\u201380."},{"key":"B17","series-title":"Support Care Cancer","first-page":"3695","article-title":"Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden","volume":"24","author":"Pearman TP","year":"2016","unstructured":"Pearman TP, Beaumont JL, Cella D,  Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden. Support Care Cancer 2016;24:3695\u20133703."},{"key":"B18","series-title":"Ann Surg Oncol","first-page":"2711","article-title":"Symptom burden at the end of life for neuroendocrine tumors: an analysis of 2579 prospectively collected patient-reported outcomes","volume":"26","author":"Hallet J","year":"2019","unstructured":"Hallet J, Davis LE, Mahar AL,  Symptom burden at the end of life for neuroendocrine tumors: an analysis of 2579 prospectively collected patient-reported outcomes. Ann Surg Oncol 2019;26:2711\u20132721."},{"key":"B19","series-title":"Endocr Relat Cancer","first-page":"e220226","article-title":"Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care","volume":"30","author":"Del Rivero J","year":"2023","unstructured":"Del Rivero J, Mailman J, Rabow MW,  Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. Endocr Relat Cancer 2023;30:e220226."},{"key":"B20","series-title":"J Oncol Pract","first-page":"51","article-title":"Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?","volume":"9","author":"Rocque GB","year":"2013","unstructured":"Rocque GB, Barnett AE, Illig LC,  Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care? J Oncol Pract 2013;9:51\u201354."},{"key":"B21","series-title":"J Gen Intern Med","first-page":"651","article-title":"Differences in end-of-life decision making among black and white ambulatory cancer patients","volume":"11","author":"McKinley ED","year":"1996","unstructured":"McKinley ED, Garrett JM, Evans AT,  Differences in end-of-life decision making among black and white ambulatory cancer patients. J Gen Intern Med 1996;11:651\u2013656."},{"key":"B22","series-title":"Crit Care Med","first-page":"S373","article-title":"Race and the intensive care unit: disparities and preferences for end-of-life care","volume":"31","author":"Degenholtz HB","year":"2003","unstructured":"Degenholtz HB, Thomas SB, Miller MJ. Race and the intensive care unit: disparities and preferences for end-of-life care. Crit Care Med 2003;31:S373\u2013378."},{"key":"B23","series-title":"J Immigr Minor Health","first-page":"1277","article-title":"Facilitators and barriers for advance care planning among ethnic and racial minorities in the U.S.: a systematic review of the current literature","volume":"20","author":"Hong M","year":"2018","unstructured":"Hong M, Yi EH, Johnson KJ,  Facilitators and barriers for advance care planning among ethnic and racial minorities in the U.S.: a systematic review of the current literature. J Immigr Minor Health 2018;20:1277\u20131287."},{"key":"B24","series-title":"J Pain Symptom Manage","first-page":"1408","article-title":"Culture and palliative care: preferences, communication, meaning, and mutual decision making","volume":"55","author":"Cain CL","year":"2018","unstructured":"Cain CL, Surbone A, Elk R,  Culture and palliative care: preferences, communication, meaning, and mutual decision making. J Pain Symptom Manage 2018;55:1408\u20131419."},{"key":"B25","series-title":"Support Care Cancer","first-page":"1251","article-title":"Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation","volume":"22","author":"Kypriotakis G","year":"2014","unstructured":"Kypriotakis G, Francis LE, O\u2019Toole E,  Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation. Support Care Cancer 2014;22:1251\u20131259."},{"key":"B26","series-title":"J Palliat Med","first-page":"1329","article-title":"Racial and ethnic disparities in palliative care","volume":"16","author":"Johnson KS","year":"2013","unstructured":"Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med 2013;16:1329\u20131334."},{"key":"B27","series-title":"Cancer Med","first-page":"2745","article-title":"Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study","volume":"6","author":"Zhou H","year":"2017","unstructured":"Zhou H, Zhang Y, Wei X,  Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer Med 2017;6:2745\u20132756."},{"key":"B28","series-title":"HPB (Oxford)","first-page":"217","article-title":"Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients","volume":"24","author":"Bingmer KE","year":"2022","unstructured":"Bingmer KE, Hue JJ, Sugumar K,  Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients. HPB (Oxford) 2022;24:217\u2013225."},{"key":"B29","series-title":"J Clin Oncol","first-page":"549","article-title":"Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers","volume":"21","author":"Phipps E","year":"2003","unstructured":"Phipps E, True G, Harris D,  Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers. J Clin Oncol 2003;21:549\u2013554."},{"key":"B30","series-title":"J Palliat Med","first-page":"1249","article-title":"Predictors of intensive end-of-life and hospice care in Latino and white advanced cancer patients","volume":"16","author":"Loggers ET","year":"2013","unstructured":"Loggers ET, Maciejewski PK, Jimenez R,  Predictors of intensive end-of-life and hospice care in Latino and white advanced cancer patients. J Palliat Med 2013;16:1249\u20131254."},{"key":"B31","series-title":"SSM Popul Health","first-page":"100331.","article-title":"Racial and ethnic differences in end-of-life care in the United States: evidence from the Health and Retirement Study (HRS)","volume":"7","author":"Orlovic M","year":"2019","unstructured":"Orlovic M, Smith K, Mossialos E. Racial and ethnic differences in end-of-life care in the United States: evidence from the Health and Retirement Study (HRS). SSM Popul Health 2019;7:100331."},{"key":"B32","series-title":"J Natl Compr Canc Netw","first-page":"439","article-title":"Patterns of palliative care consultation among elderly patients with cancer","volume":"14","author":"Roeland EJ","year":"2016","unstructured":"Roeland EJ, Triplett DP, Matsuno RK,  Patterns of palliative care consultation among elderly patients with cancer. J Natl Compr Canc Netw 2016;14:439\u2013445."},{"key":"B33","series-title":"BMJ Support Palliat Care","first-page":"e1085","article-title":"Public knowledge and attitudes concerning palliative care","volume":"14","author":"Zimmermann C","year":"2024","unstructured":"Zimmermann C, Wong JL, Swami N,  Public knowledge and attitudes concerning palliative care. BMJ Support Palliat Care 2024;14:e1085\u20131095."},{"key":"B34","series-title":"Am J Hosp Palliat Care","first-page":"202","article-title":"Methods for improving the quality of palliative care delivery: a systematic review","volume":"31","author":"Lau BD","year":"2014","unstructured":"Lau BD, Aslakson RA, Wilson RF,  Methods for improving the quality of palliative care delivery: a systematic review. Am J Hosp Palliat Care 2014;31:202\u2013210."},{"key":"B35","series-title":"JAMA","first-page":"224","article-title":"Default palliative care consultation for seriously ill hospitalized patients: a pragmatic cluster randomized trial","volume":"331","author":"Courtright KR","year":"2024","unstructured":"Courtright KR, Madden V, Bayes B,  Default palliative care consultation for seriously ill hospitalized patients: a pragmatic cluster randomized trial. JAMA 2024;331:224\u2013232."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/8\/article-p314.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/8\/article-p314.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/8\/article-p314.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:36:58Z","timestamp":1754397418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/8\/article-p314.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.7024","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"type":"print","value":"1540-1405"},{"type":"electronic","value":"1540-1413"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}